Teen's Unexplained Symptoms Lead to Serious Diagnosis: Recognizing Warning Signs

Antithrombin III is a protein produced by the liver that plays a crucial role in regulating blood clotting. It works by inhibiting several clotting factors in the blood, particularly thrombin and factor Xa, which helps prevent excessive blood clot formation. When antithrombin III levels are too low, the blood may clot too easily, increasing the risk of dangerous blood clots in veins and arteries. This condition is known as antithrombin III deficiency and can be either inherited or acquired during a person's lifetime.

Testing for antithrombin III levels is typically ordered when a person has experienced unexplained or recurrent blood clots, particularly deep vein thrombosis or pulmonary embolism. The test may also be recommended for individuals with a family history of blood clotting disorders or for pregnant women with a history of pregnancy complications related to clotting. Healthcare providers often perform this test as part of a broader evaluation for thrombophilia, which is an increased tendency to form blood clots. The test is usually done through a simple blood draw from a vein in the arm.

Low antithrombin III levels can result from genetic mutations that are passed down through families, or they may develop due to various medical conditions. Acquired deficiency can occur in people with liver disease, since the liver produces this protein, or in those with severe infections, blood clots, or certain cancers. Other causes include taking certain medications like heparin, undergoing surgery, or experiencing significant blood loss. Pregnant women and those taking birth control pills may also have temporarily decreased levels.

High antithrombin III levels are less common and generally less clinically significant than low levels. Elevated levels may be seen in people taking certain anticoagulant medications, those with kidney disease, or individuals with vitamin K deficiency. In some cases, increased levels may occur after a blood clot has resolved or during the acute phase of hepatitis. Understanding antithrombin III levels helps healthcare providers assess bleeding and clotting risks and determine appropriate treatment strategies, which may include anticoagulant therapy or antithrombin concentrate replacement in severe deficiency cases.